Skip to content

Clinical trials

Thromboembolism trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: Portugal Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20122
20131
20142
20162
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Boehringer Ingelheim3
AstraZeneca1
Boston Scientific Corporation1
CHAD1
Centro Hospitalar Tondela-Viseu1
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism12
Stroke4
Atrial Fibrillation3
Thrombosis3
Venous Thromboembolism3
Cardiovascular Diseases2
Embolism and Thrombosis2
Ischemic Attack, Transient2
Vascular Diseases2
Arrhythmias, Cardiac1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.